Pfizer CEO Albert Bourla argued the Biden administration’s plan will cut profits and force Big Pharma companies to pull back on developing medicines.
This article was originally published on CNBC
Pfizer CEO Albert Bourla argued the Biden administration’s plan will cut profits and force Big Pharma companies to pull back on developing medicines.
This article was originally published on CNBC